AI assistant
Sending…
Oncopeptides — Major Shareholding Notification 2020
Jul 1, 2020
3091_iss_2020-07-01_10cba780-e28c-4ff4-aa7a-10452ce94507.pdf
Major Shareholding Notification
Open in viewerOpens in your device viewer

Issuer Oncopeptides AB
Holder
Fjärde AP-fonden
Instrument
| Instrument | Aktier |
|---|---|
| Before the transaction | |
| Shares | 3,055,755 |
| Voting rights | 3,055,755 |
| Transaction | |
| Reason for major shareholding notification Buy | |
| Date | 30/06/2020 |
| Limit for number of shares | 5 % |
| Limit for number of votes | 5 % |
| After the transaction | |
| Quantity | |
| Shares | 3,140,755 |
| Directly held voting rights | 3,140,755 |
| Indirectly held voting rights | 0 |
| Percentage | |
| Directly held shares | 5.11 % |
| Directly held voting rights | 5.11 % |
| Indirectly held voting rights | 0 % |
Resulting distribution of total holdings
| Percentage of voting rights: |
Number of underlying shares: |
|
|---|---|---|
| Shares | 5.11 % | 3,140,755 |
| Instruments - FITA Ch. 4, section 2, first paragraph, line 2 |
||
| Instruments - FITA Ch. 4, section 2, first paragraph, line 3 |
||
| - Physically settled | ||
| - Cash settled | ||
| Total | 5.11 % | 3,140,755 |
| Group total holdings |
||
| Voting rights 3,140,755 |
||
| Percentage of voting rights 5.11 | ||
| Published | ||
| 01/07/2020 21:21 | ||
| Contact | ||
| Name Jannis Kitsakis |
||
| Phone 070-6038023 Email [email protected] |
||

[email protected] Tfn 08-408 980 37 Fax 08-24 39 25
More from Oncopeptides
Declaration of Voting Results & Voting Rights Announcements
2026
May 21
Declaration of Voting Results & Voting Rights Announcements
2026
May 21
Interim / Quarterly Report
2026
May 13
Interim / Quarterly Report
2026
May 13
Regulatory Filings
2026
May 11
Regulatory Filings
2026
May 11
Annual Report (ESEF)
2026
Apr 28
Major Shareholding Notification
2026
Apr 24
Major Shareholding Notification
2026
Apr 21
Proxy Solicitation & Information Statement
2026
Apr 16